Vitamin D supplementation for cystic fibrosis

Area of Science:

• Medical research
• Nutritional science
• Genetics

Background:

• Cystic fibrosis (CF) is a genetic disorder affecting multiple organs.
• Pancreatic insufficiency in CF can lead to malabsorption of fat-soluble vitamins, including vitamin D.
• Vitamin D plays a crucial role in calcium homeostasis, bone mineralization, and may have extraskeletal functions.

Purpose of the Study:

• To evaluate the impact of vitamin D supplementation on vitamin D deficiency rates in CF patients.
• To assess the effects of vitamin D supplementation on respiratory outcomes in CF.
• To determine the incidence of vitamin D toxicity in CF patients receiving supplementation.

Main Methods:

• Systematic review of randomized and quasi-randomized controlled trials.
• Searched the Cochrane CF and Genetic Disorders Group Trials Register.
• Included trials comparing vitamin D supplementation to placebo in CF patients, irrespective of pancreatic function.

Main Results:

• Three studies were identified, with data available from two, involving 41 adults and children with CF.
• No significant differences in primary or secondary outcomes were observed between vitamin D and placebo groups in the included studies.
• The studies had limitations including small sample sizes, differing supplementation protocols, and undefined participant characteristics, precluding direct comparison.

Conclusions:

• Current evidence from limited, small trials does not support a benefit or harm from vitamin D supplementation in CF.
• Adherence to existing CF guidelines regarding vitamin D is recommended pending further research.
• More robust studies are needed to establish the efficacy and safety of vitamin D supplementation in cystic fibrosis.